Evaluation of serum ghrelin, nesfatin-1, irisin, and vasoactive intestinal peptide levels in temporal lobe epilepsy patients with and without drug resistance: a cross-sectional study-Reference-Cited by-同舟云学术

Evaluation of serum ghrelin, nesfatin-1, irisin, and vasoactive intestinal peptide levels in temporal lobe epilepsy patients with and without drug resistance: a cross-sectional study

Published:2021-02 Issue:2 Volume:67 Page:207-212
ISSN:1806-9282
Container-title:Revista da Associação Médica Brasileira
language:
Short-container-title:Rev. Assoc. Med. Bras.

Author:

Erkec Ozlem Ergul¹^ORCID,Milanlıoğlu Aysel¹^ORCID,Komuroglu Ahmet Ufuk¹^ORCID,Kara Mehmet¹^ORCID,Huyut Zubeyir¹^ORCID,Keskin Sıddık¹

Affiliation:

1. Van Yüzüncü Yıl University, Turkey

Publisher

FapUNIFESP (SciELO)

Subject

General Medicine

Link

http://www.scielo.br/pdf/ramb/v67n2/1806-9282-ramb-67-02-0207.pdf

Reference38 articles.

1. Epilepsy,2019

2. Drug-resistant epilepsy: definition and treatment alternatives;López González FJ;Neurologia,2015

3. Molecular neurology;Waxman S,2010

4. Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial;Engel Jr J;JAMA,2012

5. Drug resistance in epilepsy: clinical ımpact, potential mechanisms, and new ınnovative treatment options;Löscher W;Pharmacol Rev,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exercise-produced irisin effects on brain-related pathological conditions;Metabolic Brain Disease;2024-08-15

2. Irisin: A bridge between exercise and neurological diseases;Heliyon;2022-12

3. Irisin: A promising treatment for neurodegenerative diseases;Neuroscience;2022-08

4. Targeting the Ghrelin Receptor as a Novel Therapeutic Option for Epilepsy;Biomedicines;2021-12-27